Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: #Breeze who wrote (22590)	1/22/2025 1:04:46 PM
From: Kirk ©	2 Recommendations Recommended By da_spot Return to Sender Respond to of 26422

Thanks. COHR could be a HUGE winner despite the huge gains from adding when low already. coherent.com Coherent Introduces Pin-Hole Array Biochips for Medical Diagnostics PITTSBURGH, Jan. 22, 2025 (GLOBE NEWSWIRE) – Coherent Corp. (NYSE: COHR), a global leader in laser and photonic solutions, today announces the launch of new pin-hole array biochips for medical diagnostics, with a focus on gene sequencing applications. Developed by the Coherent advanced optics team, this groundbreaking approach consolidates the entire production process, addressing key challenges in cost, efficiency, and supply chain management for professionals in the diagnostic field. Pin-hole array biochips are indispensable tools in applications such as medical diagnostics, disease prediction, clinical treatment, drug development, and food safety testing. The increasing demand for biochips that combine precision, reliability, and scalability underscores the strategic importance of the advanced optics platform. Coherent prompted the highly integrated approach from custom wafer processing, Cr patterning, advanced semiconductor photolithography, and high-precision assembly in house. “Our one-stop solution for pin-hole array biochips redefines industry standards for efficiency and quality,” said Guanglong Yu, Vice President at Coherent. “By offering a fully integrated approach, we empower researchers and clinicians to focus on innovation while benefiting from simplified operations and reduced costs.” Pin-hole array biochips from Coherent are available in a variety of formats, from bare wafers to fully assembled modules, providing unparalleled flexibility for diverse customer applications. This versatility accelerates customer project timelines while enhancing operational efficiency. Coherent further supports imaging and diagnostics applications with a suite of complementary products, including EX/EM filters, dichroic mirrors, light engines, objectives, and tube lenses, creating a complete ecosystem for imaging and diagnostic applications. For more information, visit coherent.com.

To: #Breeze who wrote (22590)

1/28/2025 10:21:33 AM

From: Kirk ©

1 Recommendation

Recommended By
berniel

Read Replies (1) | Respond to of 26422

eWave has the same "issues" as any modeling software I've worked with... new data outside the "known universe" causes it to "blow up." This case the "new data" came from China. Fundamentally, this seems to be good news for COHR products but short term, it was mistaken for a baby tossed with the bathwater.

Message #22590 from #Breeze at 1/22/2025 9:57:19 AM

Kirk, here's a COHR Wave Count Update. Wave (v) of Minute Wave (circle) iii is in play with a target of 125 -134. Breeze

This decline to the 200-dma for COHR is no exception and is why I take profits all the way up... then I add a bit of hysteresis on when to buy back (exponentially rising stocks need a bit more room, say 30% vs 10% for a normal trading range for a stock working well with eWave.)

I look forward to when you can call an eWave bottom... My deep sea nets got some already with a small profit but the next big support is at 75 which happens to coincide with 61.8% Fib level... so maybe I am frontrunning your call!